Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial

BACKGROUND: The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality data and a systematic literature review, we estimated the number of premature deaths that might be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ker, Katharine, Kiriya, Junko, Perel, Pablo, Edwards, Phil, Shakur, Haleema, Roberts, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314558/
https://www.ncbi.nlm.nih.gov/pubmed/22380715
http://dx.doi.org/10.1186/1471-227X-12-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314558/
https://www.ncbi.nlm.nih.gov/pubmed/22380715
http://dx.doi.org/10.1186/1471-227X-12-3

Ejemplares similares